Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15640%2F23%3A73619088" target="_blank" >RIV/61989592:15640/23:73619088 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/61988987:17110/23:A2402L1U RIV/00098892:_____/23:10157994 RIV/27661989:_____/23:10003397

Výsledek na webu

<a href="https://tlcr.amegroups.com/article/view/74398/pdf" target="_blank" >https://tlcr.amegroups.com/article/view/74398/pdf</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.21037/tlcr-22-801" target="_blank" >10.21037/tlcr-22-801</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients

Popis výsledku v původním jazyce

Surgical treatment of early-stage non-small cell lung cancer (NSCLC) yields highest expectations for recovery. However, the frequency of further disease progression remains high since micrometastatic disease may be undetected by conventional diagnostic methods. We test the presence and prognostic impact of circulating tumor cells (CTCs) in peripheral blood (PB), tumor-draining pulmonary blood (TDB) and bone marrow (BM) samples from NSCLC patients.Methods: The presence of circulating/disseminated tumor cells (CTCs/DTCs) was detected by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis in PB, TDB and BM samples before surgery in 119 stage IA-IIIA NSCLC patients (Clinical Trial NS10285).Results: NSCLC patients with the presence of carcinoembryonic antigen (CEA) mRNA-positive CTCs/ DTCs in TDB and BM had significantly shorter cancer-specific survival (CSS) (P&lt;0.013, resp. P&lt;0.038). Patients with the presence of epithelial cellular adhesion molecule (EpCAM) mRNA-positive CTCs in TDB samples had significantly shorter CSS and disease-free survival (DFS) (P&lt;0.031, resp. P&lt;0.045). A multivariate analysis identified the presence of CEA mRNA-positive CTCs in the PB as an independent negative prognostic factor for DFS (P&lt;0.005). No significant correlation of CTCs/DTCs presence and other prognostic factors was found.Conclusions: In NSCLC patients undergoing radical surgery, the presence of CEA and EpCAM mRNApositive CTCs/DTCs is associated with poorer survival.

Název v anglickém jazyce

Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients

Popis výsledku anglicky

Surgical treatment of early-stage non-small cell lung cancer (NSCLC) yields highest expectations for recovery. However, the frequency of further disease progression remains high since micrometastatic disease may be undetected by conventional diagnostic methods. We test the presence and prognostic impact of circulating tumor cells (CTCs) in peripheral blood (PB), tumor-draining pulmonary blood (TDB) and bone marrow (BM) samples from NSCLC patients.Methods: The presence of circulating/disseminated tumor cells (CTCs/DTCs) was detected by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) analysis in PB, TDB and BM samples before surgery in 119 stage IA-IIIA NSCLC patients (Clinical Trial NS10285).Results: NSCLC patients with the presence of carcinoembryonic antigen (CEA) mRNA-positive CTCs/ DTCs in TDB and BM had significantly shorter cancer-specific survival (CSS) (P&lt;0.013, resp. P&lt;0.038). Patients with the presence of epithelial cellular adhesion molecule (EpCAM) mRNA-positive CTCs in TDB samples had significantly shorter CSS and disease-free survival (DFS) (P&lt;0.031, resp. P&lt;0.045). A multivariate analysis identified the presence of CEA mRNA-positive CTCs in the PB as an independent negative prognostic factor for DFS (P&lt;0.005). No significant correlation of CTCs/DTCs presence and other prognostic factors was found.Conclusions: In NSCLC patients undergoing radical surgery, the presence of CEA and EpCAM mRNApositive CTCs/DTCs is associated with poorer survival.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

10608 - Biochemistry and molecular biology

Projekt

Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2023

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Translational Lung Cancer Research

ISSN

2218-6751

e-ISSN

—

Svazek periodika

12

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

CN - Čínská lidová republika

Počet stran výsledku

17

Strana od-do

1034-1050

Kód UT WoS článku

000975374600001

EID výsledku v databázi Scopus

2-s2.0-105012940770